Inactief instrument

Koers Raptor Pharmaceutical Corp

Aandelen

slotkoers Nasdaq Andere beurzen
- ^USD	-

Depomed : Le laboratoire Depomed résigné à se vendre-sources	16-09-16
Exclusive: Drugmaker Depomed prepares to explore a sale - sources	15-09-16
Brower Piven Commences An Investigation Into The Proposed Sale Of Raptor Pharmaceutical Corp. And Encourages Shareholders To Contact The Firm For Additional Information	15-09-16
Raptor Pharmaceutical : Acquisition May Not Be in the Best Interests of RPTP Shareholders	14-09-16
Brower Piven Commences An Investigation Into The Proposed Sale Of Raptor Pharmaceutical Corp. And Encourages Investors To Contact The Firm For Additional Information	12-09-16

Managers	Titel	Leeftijd	Van
Paul Hoelscher DFI	Director of Finance/CFO	59	25-10-16
Kim Lee IRC	Investor Relations Contact	-	23-10-14
Françoise de Craecker PRN	Corporate Officer/Principal	62	-

Besturend	Titel	Leeftijd	Van
Gregg Lapointe CHM	Chairman	65	01-01-15
Timothy Walbert BRD	Director/Board Member	57	11-04-11
Paul Hoelscher DFI	Director of Finance/CFO	59	25-10-16

Sector

	Vaira. 1 jan.	Kapi.
VERTEX PHARMACEUTICALS INCORPORATED	-2,31%	103 mld.
REGENERON PHARMACEUTICALS, INC.	+0,56%	95,28 mld.
ARGENX SE	+1,69%	22,15 mld.
BIONTECH SE	-17,37%	21,02 mld.
GENMAB A/S	-9,30%	18,15 mld.
WUXI APPTEC CO., LTD.	-41,01%	16,73 mld.
BEIGENE, LTD.	-14,85%	16,05 mld.
NEUROCRINE BIOSCIENCES, INC.	+3,21%	13,68 mld.
SAREPTA THERAPEUTICS, INC.	+33,54%	12,17 mld.